It was also reported that the phosphorylation levels of JAK2 and STAT3 were significantly elevated in cisplatin-resistant NSCLC cell lines compared with those in cisplatin-sensitive NSCLC cell lines [39]. This evidence concerns the gene JAK2 and non-small cell lung carcinoma.